Moreover, KRAS mutation is one of the most common genomic alternations in gallbladder cancer (15, 24, 25), and KRAS-associated genes were upregulated in GBC cell lines compared with L-2F7 (Supplementary Figure 3A). This evidence concerns the gene KRAS and gallbladder cancer.